acc2601 |
PP2A |
methylation |
unclear |
human |
Glioblastoma |
U87-MG |
Temozolomide |
Enhancing |
5.0 (High)
|
37500619
|
acc2602 |
PP2A |
methylation |
unclear |
human |
Glioblastoma |
U251MG |
Radiotherapy |
Enhancing |
4.5 (High)
|
37500619
|
acc2603 |
PP2A |
methylation |
unclear |
human |
Glioblastoma |
U251MG |
Temozolomide |
Enhancing |
5.0 (High)
|
37500619
|
acc2604 |
AROS |
methylation |
Lys27 |
human |
Colorectal Cancer |
LoVo |
Radiotherapy |
Impairing |
4.5 (High)
|
37756162
|
acc2605 |
AROS |
methylation |
Lys27 |
human |
Colorectal Cancer |
HCT116 |
Radiotherapy |
Impairing |
4.5 (High)
|
37756162
|
acc2606 |
NADPH |
oxidation |
unclear |
human |
Breast Cancer |
|
Carbon monoxide |
Impairing |
4.5 (High)
|
4004771
|
acc2607 |
NADPH |
oxidation |
unclear |
human |
Breast Cancer |
|
antibody against cytochrome P-450 |
Impairing |
4.5 (High)
|
4004771
|
acc2608 |
BAD |
phosphorylation |
unclear |
human |
Colorectal Cancer |
COLO205 |
Gossypol |
Associated |
4.0 (Moderate) |
17597109
|
acc2609 |
BAD |
phosphorylation |
unclear |
human |
Colorectal Cancer |
HT29 |
Gossypol |
Associated |
4.0 (Moderate) |
17597109
|
acc2610 |
BAD |
phosphorylation |
unclear |
human |
Colorectal Cancer |
COLO205 |
Gossypol acetic acid |
Associated |
4.0 (Moderate) |
17597109
|
acc2611 |
BAD |
phosphorylation |
unclear |
human |
Colorectal Cancer |
HT29 |
Gossypol acetic acid |
Associated |
4.0 (Moderate) |
17597109
|
acc2612 |
p53 |
acetylation |
Lys382 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Enhancing |
5.0 (High)
|
19676051
|
acc2613 |
ATM |
phosphorylation |
Ser1981 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
4.0 (Moderate) |
19676051
|
acc2614 |
ATM |
phosphorylation |
Ser1981 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
5.0 (High)
|
19676051
|
acc2615 |
Chk1 |
phosphorylation |
Ser345 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
5.0 (High)
|
19676051
|
acc2616 |
Chk2 |
phosphorylation |
Thr68 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
5.0 (High)
|
19676051
|
acc2617 |
H2AX |
phosphorylation |
unclear |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
4.0 (Moderate) |
19676051
|
acc2618 |
H2AX |
phosphorylation |
unclear |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
4.5 (High)
|
19676051
|
acc2619 |
p53 |
phosphorylation |
Ser15 |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
5.0 (High)
|
19676051
|
acc2620 |
RPA-2 |
phosphorylation |
unclear |
human |
Ovarian Cancer |
IGROV-1 |
ST1926 |
Associated |
5.0 (High)
|
19676051
|
acc2621 |
Akt |
phosphorylation |
Ser473 |
mouse |
Myocardial Infarction |
|
Rapamycin |
Associated |
4.0 (Moderate) |
31738412
|
acc2622 |
S6 |
phosphorylation |
Ser235 |
mouse |
Myocardial Infarction |
|
Rapamycin |
Associated |
4.0 (Moderate) |
31738412
|
acc2623 |
S6 |
phosphorylation |
Ser236 |
mouse |
Myocardial Infarction |
|
Rapamycin |
Associated |
4.0 (Moderate) |
31738412
|
acc2624 |
STAT3 |
phosphorylation |
Tyr705 |
mouse |
Myocardial Infarction |
|
Rapamycin |
Associated |
4.0 (Moderate) |
31738412
|
acc2625 |
PDGFR |
phosphorylation |
Tyr |
mouse |
Pi-Turnover |
NIH 3T3 |
Glucopiericidin A |
Associated |
2.0 (Low)
|
8653074
|
acc2626 |
PLC-gamma1 |
phosphorylation |
Tyr783 |
mouse |
Pi-Turnover |
NIH 3T3 |
Glucopiericidin A |
Associated |
2.0 (Low)
|
8653074
|
acc2627 |
SNAP-25 |
phosphorylation |
Ser187 |
rat |
Synaptic Plasticity |
PC12 cells |
PMA |
Associated |
2.0 (Low)
|
8662851
|
acc2628 |
PLC-gamma2 |
phosphorylation |
Tyr |
mouse |
Phospholipid Hydrolysis |
Plcg1(-/-) cells |
Platelet-derived growth factor (PDGF) |
Associated |
4.0 (Moderate) |
9685408
|
acc2629 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
|
PGE2 |
Associated |
4.0 (Moderate) |
11779161
|
acc2630 |
Akt |
phosphorylation |
unclear |
rat |
Hypertension |
|
Wortmannin |
Associated |
4.0 (Moderate) |
12003815
|
acc2631 |
eNOS |
phosphorylation |
Ser1176 |
rat |
Hypertension |
|
Wortmannin |
Associated |
4.0 (Moderate) |
12003815
|
acc2632 |
nNOS |
phosphorylation |
Ser847 |
rat |
Ischemia |
|
KN93 |
Associated |
4.0 (Moderate) |
12218415
|
acc2633 |
ERK |
phosphorylation |
unclear |
mouse |
Apoptosis of Cardiac Muscle Cell |
HL-1 |
Mercury |
Associated |
4.0 (Moderate) |
12788478
|
acc2634 |
GATA4 |
phosphorylation |
unclear |
mouse |
Apoptosis of Cardiac Muscle Cell |
HL-1 |
Mercury |
Associated |
4.0 (Moderate) |
12788478
|
acc2635 |
JAK2 |
phosphorylation |
Tyr1007 |
human |
Melanoma |
LU1205 |
PD98059 + LY294002 |
Associated |
4.0 (Moderate) |
12821943
|
acc2636 |
JAK2 |
phosphorylation |
Tyr1008 |
human |
Melanoma |
LU1205 |
PD98059 + LY294002 |
Associated |
4.0 (Moderate) |
12821943
|
acc2637 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
LU1205 |
PD98059 + LY294002 |
Associated |
4.0 (Moderate) |
12821943
|
acc2638 |
STAT5 |
phosphorylation |
Tyr694 |
human |
Melanoma |
LU1205 |
PD98059 + LY294002 |
Associated |
4.0 (Moderate) |
12821943
|
acc2639 |
NR2A |
phosphorylation |
Tyr1472 |
rat |
Cerebral Ischemia |
|
Lithium |
Associated |
4.0 (Moderate) |
12932824
|
acc2640 |
RhoA |
geranylgeranylation |
unclear |
human |
Colorectal Cancer |
COLO 320DM |
GGTI-298 |
Associated |
4.0 (Moderate) |
14598891
|
acc2641 |
Tau |
phosphorylation |
Ser199 |
human |
Alzheimer's Disease |
SH-SY5Y |
Lithium |
Associated |
4.0 (Moderate) |
15184080
|
acc2642 |
Tau |
phosphorylation |
Ser202 |
human |
Alzheimer's Disease |
SH-SY5Y |
Lithium |
Associated |
4.0 (Moderate) |
15184080
|
acc2643 |
Tau |
phosphorylation |
Thr205 |
human |
Alzheimer's Disease |
SH-SY5Y |
Lithium |
Associated |
4.0 (Moderate) |
15184080
|
acc2644 |
Tau |
phosphorylation |
Ser396 |
human |
Alzheimer's Disease |
SH-SY5Y |
Lithium |
Associated |
4.0 (Moderate) |
15184080
|
acc2645 |
Tau |
phosphorylation |
Ser404 |
human |
Alzheimer's Disease |
SH-SY5Y |
Lithium |
Associated |
4.0 (Moderate) |
15184080
|
acc2646 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Cancer |
BCap37 |
Paclitaxel |
Enhancing |
5.0 (High)
|
15269161
|
acc2647 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Cancer |
KB |
Paclitaxel |
Enhancing |
5.0 (High)
|
15269161
|
acc2648 |
Cdc2 |
phosphorylation |
Tyr15 |
human |
Cancer |
BCap37 |
Paclitaxel |
Enhancing |
5.0 (High)
|
15269161
|
acc2649 |
Cdc2 |
phosphorylation |
Tyr15 |
human |
Cancer |
KB |
Paclitaxel |
Enhancing |
5.0 (High)
|
15269161
|
acc2650 |
ATM |
phosphorylation |
Ser1981 |
human |
Cancer |
A2780 |
Irofulven |
Associated |
4.0 (Moderate) |
15269203
|